HomeTSBX • NASDAQ
add
Turnstone Biologics Corp
Previous close
$0.36
Year range
$0.29 - $2.40
Market cap
8.21M USD
Avg Volume
379.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.56M | -74.04% |
Net income | -5.49M | 74.23% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.56M | 74.21% |
Effective tax rate | -0.22% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.69M | -73.26% |
Total assets | 21.11M | -72.54% |
Total liabilities | 6.34M | -62.98% |
Total equity | 14.76M | — |
Shares outstanding | 23.14M | — |
Price to book | 0.55 | — |
Return on assets | -57.05% | — |
Return on capital | -77.53% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.49M | 74.23% |
Cash from operations | -4.30M | 72.97% |
Cash from investing | 935.00K | -95.06% |
Cash from financing | — | — |
Net change in cash | -3.37M | -213.51% |
Free cash flow | -3.52M | 56.17% |
About
Founded
2014
Headquarters
Website
Employees
3
